Anti-anxiety effects of Apocynum venetum L. in the elevated plus maze test

被引:117
作者
Grundmann, Oliver
Nakajima, Jun-Ichiro
Seo, Shujiro
Butterweck, Veronika
机构
[1] Univ Florida, Coll Pharm, Dept Pharmaceut, Gainesville, FL 32610 USA
[2] Tokiwa Phytochem Co, Chiba 2850801, Japan
关键词
anxiolytic effect; benzodiazepines; elevated plus maze; open field; Apocynum venetum; GABA receptor; buspirone; 5-HT1A receptor;
D O I
10.1016/j.jep.2006.09.035
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
The purpose of this study was to characterize the putative anxiolytic-like activity of an ethanolic extract prepared from the leaves of Apocynum venetum (AV) using the elevated plus maze (EPM) in mice. Male C75BL/6 mice were either treated orally with the AV extract or the positive controls diazepam and buspirone, respectively, 1 h before behavioral evaluation in the EPM. A single treatment of AV extract markedly increased the percentage time spent on and the number of entries into the open arms of the EPM in doses of 30 and 125 mg/kg p.o., respectively. This effect was comparable to that of the benzodiazepine diazepam (1.5 mg/kg p.o.) and the 5-HT1A agonist buspirone (10 mg/kg p.o.). The effects of AV in 125 mg/kg were effectively antagonized by the benzodiazepine antagonist flumazenil (0.3 mg/kg i.p.). However, the effects of AV extract could only partially be blocked by the unspecific 5-HT1A receptor antagonist WAY-100635 (0.5 mg/kg i.p.). Neither diazepam and buspirone nor the AV extract produced any overt behavioral change or motor dysfunction in the open field test. These results indicate that AV extract is an effective anxiolytic agent, and suggest that the anxiolytic-like activities of this plant are mainly mediated via the GABAergic system. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:406 / 411
页数:6
相关论文
共 33 条
[1]   Long-term effects of an Apocynum venetum extract on brain monoamine levels and β-AR density in rats [J].
Butterweck, V ;
Simbrey, K ;
Seo, S ;
Sasaki, T ;
Nishibe, S .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2003, 75 (03) :557-564
[2]   Antidepressant effects of Apocynum venetum leaves in a forced swimming test [J].
Butterweck, V ;
Nishibe, S ;
Sasaki, T ;
Uchida, M .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2001, 24 (07) :848-851
[3]   Hormesis: A highly generalizable and reproducible phenomenon with important implications for risk assessment [J].
Calabrese, EJ ;
Baldwin, LA ;
Holland, CD .
RISK ANALYSIS, 1999, 19 (02) :261-281
[4]   U-shaped dose-responses in biology, toxicology, and public health [J].
Calabrese, EJ ;
Baldwin, LA .
ANNUAL REVIEW OF PUBLIC HEALTH, 2001, 22 :15-33
[5]  
CARLSTEDT T, 1986, PERIPH NERVE REPAIR, V1, P37
[6]   USE OF THE ELEVATED PLUS-MAZE IN THE SEARCH FOR NOVEL ANXIOLYTIC AGENTS [J].
DAWSON, GR ;
TRICKLEBANK, MD .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1995, 16 (02) :33-36
[7]   The anxiolytic-like effect of MCI-225, a selective NA reuptake inhibitor with 5-HT3 receptor antagonism [J].
Eguchi, J ;
Inomata, Y ;
Saito, K .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2001, 68 (04) :677-683
[8]   Trends in alternative medicine use in the United States, 1990-1997 - Results of a follow-up national survey [J].
Eisenberg, DM ;
Davis, RB ;
Ettner, SL ;
Appel, S ;
Wilkey, S ;
van Rompay, M ;
Kessler, RC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (18) :1569-1575
[9]   Modification of the anxiolytic action of 5-MT1A compounds by GABA-benzodiazepine agents in rats [J].
Fernández-Guasti, A ;
López-Rubalcava, C .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1998, 60 (01) :27-32
[10]   A PHARMACOLOGICAL PROFILE OF THE SELECTIVE SILENT 5-HT1A RECEPTOR ANTAGONIST, WAY-100635 [J].
FORSTER, EA ;
CLIFFE, IA ;
BILL, DJ ;
DOVER, GM ;
JONES, D ;
REILLY, Y ;
FLETCHER, A .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 281 (01) :81-88